GRCE
Grace Therapeutics, Inc.$1.94+0.00 (—)Prev Close$1.94·MCap$55.5M·P/E—·Vol—·Yield—
▲
Buys (12M)
10
$774.5K
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$774.5K
●
Active Insiders
2
last 12 mo
Over the past 12 months, insider activity at Grace Therapeutics, Inc. (GRCE) has been exclusively buying, with 10 insider purchases totaling $774.5K and 0 insider sales totaling $0.00. The most recent insider transaction was by Opaleye Management Inc. (10 percent owner), who purchased $158.6K worth of shares on Oct 26, 2026. Grace Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $55.5M.
GRCE Insider Trading Activity
GRCE Insider Buying Activity
The following table shows recent insider purchases of Grace Therapeutics, Inc. (GRCE) stock reported via SEC Form 4 filings.
GRCE Insider Selling Activity
The following table shows recent insider sales of Grace Therapeutics, Inc. (GRCE) stock reported via SEC Form 4 filings.
No insider selling activity found for GRCE in the last 12 months.